Open AccessRituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
Author(s) -
Yamada Akihiro,
Sogabe Ayuko,
Okuda Yasuaki
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3258
Subject(s) - medicine , rituximab , rheumatoid arthritis , vasculitis , anca associated vasculitis , immunology , monoclonal antibody , arthritis , monoclonal , dermatology , disease , antibody
We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients. This suggests that shared pathogenic pathways exist between different collagen diseases.